Mixed biofilms of pathogenic Candida-bacteria: regulation mechanisms and treatment strategies

• Published in: Critical reviews in microbiology 2021-11, Vol.47 (6), p.699-727
• Main Authors: Khan, Fazlurrahman, Bamunuarachchi, Nilushi Indika, Pham, Dung Thuy Nguyen, Tabassum, Nazia, Khan, Mohd Sajjad Ahmad, Kim, Young-Mog
• Format: Article
• Language: English
• Subjects: bacteria; Candida albicans; combination therapy; interactions; mixed-biofilm; natural drugs; strategies
• ISSN: 1040-841X; 1549-7828
• DOI: 10.1080/1040841X.2021.1921696

Mixed-species biofilm is one of the most frequently recorded clinical problems. Mixed biofilms develop as a result of interactions between microorganisms of a single or multiple species (e.g. bacteria and fungi). Candida spp., particularly Candida albicans, are known to associate with various bacterial species to form a multi-species biofilm. Mixed biofilms of Candida spp. have been previously detected in vivo and on the surfaces of many biomedical instruments. Treating infectious diseases caused by mixed biofilms of Candida and bacterial species has been challenging due to their increased resistance to antimicrobial drugs. Here, we review and discuss the clinical significance of mixed Candida-bacteria biofilms as well as the signalling mechanisms involved in Candida-bacteria interactions. We also describe possible approaches for combating infections associated with mixed biofilms, such as the use of natural or synthetic drugs and combination therapy. The review presented here is expected to contribute to the advances in the biomedical field on the understanding of underlying interaction mechanisms of pathogens in mixed biofilm, and alternative approaches to treating the related infections.